en
Feedback
Pharmacology

Pharmacology

Open in Telegram

Contact admin @murtazakuchay for any Queries/promotion/copyright issue

Show more

πŸ“ˆ Analytical overview of Telegram channel Pharmacology

Channel Pharmacology (@pharma_vid) in the English language segment is an active participant. Currently, the community unites 65 654 subscribers, ranking 213 in the Medicine category and 5 049 in the India region.

πŸ“Š Audience metrics and dynamics

Since its creation on Π½Π΅Π²Ρ–Π΄ΠΎΠΌΠΎ, the project has demonstrated rapid growth, gathering an audience of 65 654 subscribers.

According to the latest data from 21 July, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 1 467 over the last 30 days and by 25 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 14.42%. Within the first 24 hours after publication, content typically collects 3.30% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 9 470 views. Within the first day, a publication typically gains 2 165 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 15.
  • Thematic interests: Content is focused on key topics such as drug, i.e., dose, treatment, cisplatin.

πŸ“ Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
β€œContact admin @murtazakuchay for any Queries/promotion/copyright issue”

Thanks to the high frequency of updates (latest data received on 22 July, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.

65 654
Subscribers
+2524 hours
+2177 days
+1 46730 days
Attracting Subscribers
No data
Any problems? Please refresh the page or contact our support manager.
Channel Posts

Data loading in progress...